Guardion Health Sciences, Inc. GHSI Income Statement

Guardion health sciences, inc. (GHSI)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16
Revenue
Medical foods
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Vision testing diagnostics
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Total Revenue
906	902	898	1,031	991	942	0	0	0	-	-	-	-	-	-	-	-
Total revenue
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-
Cost of goods sold
Medical foods
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Vision testing diagnostics
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	167	141	0	0	0
Total Cost of goods sold
356	341	367	421	412	398	385	290	232	175	107	100	84	75	0	0	0
Gross profit
549	561	531	610	579	543	581	445	342	261	119	97	83	65	0	0	0
Operating expenses
Research and development
196	194	171	144	101	231	326	427	408	259	121	36	33	33	0	0	0
Sales and marketing
2,010	1,874	1,507	1,299	1,268	1,520	1,529	1,406	1,129	599	389	359	362	389	0	0	0
General and administrative
8,430	7,425	6,613	5,656	4,202	4,934	5,705	6,033	5,765	4,683	3,815	3,187	3,314	3,339	0	0	0
Total operating expenses
12,200	11,058	8,293	7,099	5,571	6,687	7,562	7,867	7,303	5,543	4,576	3,833	3,959	4,011	0	0	0
Loss from operations
-11,651	-10,496	-7,761	-6,489	-4,992	-6,143	-6,981	-7,422	-6,961	-5,281	-4,456	-3,736	-3,875	-3,945	0	0	0
Other expenses:
Interest expense
242	258	256	252	19	2	5	6	8	23	261	539	894	1,104	0	0	0
Finance cost upon issuance of warrants
-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative warrants
-470	-292	0	0	0	-	-	-	-	-	0	0	-	-	-	-	-
Costs associated with extension of warrant expiration dates
-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-
Total other expenses
188	381	532	1,567	1,826	1,623	0	0	0	-	0	0	-	-	-	-	-
Total other expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net loss
-11,840	-10,878	-8,294	-8,057	-6,819	-7,767	-8,487	-7,924	-6,969	-5,305	-5,416	-4,973	-5,468	-5,748	0	0	0
Accretion of deemed dividend
-	-	-	-	-	-	-	-	-	601	883	818	791	760	0	0	0
Dividend declared
-	-	-	-	-	-	-	-	-	308	181	114	71	35	0	0	0
Net loss attributable to common shareholders
-	-	-	-	-	-	-	-	-	-6,215	-6,481	-5,906	-6,331	-6,543	0	0	0
Net loss per common share - basic and diluted
-0.03	-0.02	-0.07	-0.14	-0.07	-0.06	-0.11	-0.09	-0.12	-0.31	-0.07	-0.04	-0.03	-0.13	-0.06	-0.06	-0.05
Weighted average common shares outstanding - basic and diluted
78,630	66,589	36,035	22,537	20,709	20,267	20,164	20,164	20,157	-20,319	25,825	25,470	24,760	23,496	21,424	21,315	20,966
Medical Foods [Member]
Total Revenue
484	444	403	370	0	-	0	0	-	-	-	-	-	-	-	-	-
Total Cost of goods sold
183	155	157	156	0	-	0	0	-	-	-	-	-	-	-	-	-
Gross profit
301	289	245	213	0	-	0	0	-	-	-	-	-	-	-	-	-
Total operating expenses
9,198	8,026	3,951	3,720	0	-	0	0	-	-	-	-	-	-	-	-	-
Loss from operations
-8,897	-7,736	-3,705	-3,507	0	-	0	0	-	-	-	-	-	-	-	-	-
Medical Devices [Member]
Total Revenue
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Total Cost of goods sold
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Gross profit
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss from operations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Vision Testing Diagnostics [Member]
Total revenue
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Total cost of goods sold
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Gross profit
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Loss from operations
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Other [Member]
Total Revenue
0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Cost of goods sold
0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-